Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers

British Journal of Cancer

Volumn 87, Issue 12, 2002, Pages 1404-1410

  Brenner, B ^a,b   Siris, N ^a,b   Rakowsky, E ^a,b   Fenig, E ^a,b   Sulkes, A ^a,b   Lurie, H ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Locally advanced breast cancer; Prognostic factors; Tumour markers

Indexed keywords

HORMONE RECEPTOR; TAMOXIFEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CELL HETEROGENEITY; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0037011663     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600616     Document Type: Article

References (30)

1. Cheung KL, Graves CRL, Robertson FJR (2000) Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treatment Rev 26: 91-102
2. Cox DR (1972) Regression models and life tables. JR Stat Soc Ser B 34: 187-220
3. 4) breast cancer. Cancer Chemother 1: 53-59
4. EORTC Breast Cancer Cooperative Group (2000) Clinical research and treatment in breast cancer. Manual for Clinical Research and Treatment in Breast Cancer, Proceedings of the 2nd European Breast Cancer Conference, 2000, Brussels, Belgium September 26-30 4th Edition, pp 107-108
5. Fein DA, Mendenhall NP, Marsh RD, Bland KI, Copeland III EM, Million RR (1994) Results of multimodality therapy for inflammatory breast cancer: An analysis of clinical and treatment factors affecting outcome. Am Surg 60: 22-225
6. Feldman LD, Hortobagyi GN, Budzar AU, Ames FC, Blumenschein GR (1986) Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581
7. Fleming ID, Cooper JS, Henson De (eds) (1997) AJCC Cancer Staging Manual, 5th Edn. Philadelphia, PA: Lippincott-Raven
8. Fujino N, Haga Y, Sakamoto K, Egami H, Kimura M, Nishimura R, Akagi M (1986) Clinical evaluation of an immunoradiometric assay for CA 15-3 antigen associated with human mammary carcinomas: Comparison with CEA. Jpn J Clin Oncol 16: 335-346
9. Gardin G, Rosso R, Campora E, Repetto L, Naso C, Canavese G, Catturich A, Corvo R, Guenzi M, Pronzato P (1995) Locally advanced non-metastatic breast cancer: Analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 31A: 1428-1433
10. Honkoop AH, van Diest PJ, de Jong JS, Linn SC, Giaccone G, Hoekman K, Wagstaff J, Pinedo HM (1998) Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer. Br J Cancer 77: 621-626
11. Hortobagyi G, Buzdar A (1991) Locally advanced breast cancer: A review including the M.D. Anderson experience In High Risk Breast Cancer, Ragaz J, Ariel I (eds), pp 382-415. Berlin: Springer-Verlag
12. Hortobagyi G, Singletary S, McNeese M (1996) Treatment of locally advanced and inflammatory breast cancer. In Diseases of the Breast, Harris J, Lippman M, Marrow M, Hellman S (eds), pp. 585-599. Philadelphia, PA: Lippincott-Raven
13. Jaiyesimi I, Buzdar A, Hortobagyi G (1992) Inflammatory breast cancer: A review. J Clin Oncol 10: 1014-1024
14. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat 53: 457-481
15. Karlsson YA, Malmström PO, Hatschek T, Fornander TG, Söderberg M, Bengtsson N-O, Jansson TE, Sjöberg SM, Bergh JC (1998) Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide. Cancer 83: 936-947
16. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross Merrick I, Hortobagyi GN, Singletara SA (1998) Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176: 502-509
17. Lippman M, Sorace R, Bagley C, Danforth Jr D, Lichter A, Wesley M (1986) Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. NCI Monogr 1: 153-159
18. Palangie T, Mosseri V, Mihura J, Campana F, Beuzeboc P, Dorval T, Garcia-Giralt E, Jouve M, Scholl S, Asselain B (1994) Prognostic factors in inflammatory breast cancer and therapeutic implications. Eur J Cancer 30A: 921-927
19. Pierce LJ, Lippman M, Ben-Baruch N, Swain S, O'Shaughnessy J, Bader JL, Danforth D, Venzon D, Cowan KH (1992) The effect of systemic therapy on local-regional control in locally advanced breast cancer. Int J Radiol Oncol Biol Phys 23: 949-960
20. Robertson JF, Ellis IO, Pearson D, Elston CW, Nicolson RI, Blamey RW (1994) Biological factors of prognostic significance in locally advanced breast cancer. Breast Cancer Res Treat 29: 259-264
21. Safi F, Kohler I, Röttinger E, Berger H-G (1991) The value of the tumour marker CA 15-3 in diagnosing and monitoring breast cancer. Cancer 68: 574-582
22. Sanchez-Forgach ER, Mamoumas EP, Warneke J, Driscoll D, Blumenson LE, Tsangaris TN (1992) Factors affecting outcome in locally advanced breast cancer. Surg Oncol 1: 347-355
23. Sataloff DM, Mason BA, Prestipino AJ, Seinige UL, Lieber CP, Baloch Z (1995) Pathological response to induction chemotherapy in locally advanced carcinoma of the breast: Determinant of outcome. J Am Coll Surg 180: 297-306
24. Valagussa P, Zambetti M, Bonadonna G, Zukaii R, Mezzanotte G, Veronesi U (1990) Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy. Breast Cancer Res Treat 15: 137-147
25. Valero V, Buzdar A, Hortobagyi G (1996) Locally advanced breast cancer. Oncologist 1: 8-17
26. van der Linden J, Baak J, Postma T, Lindeman J, Meyer CJ (1985) Monitoring serum CEA in women with primary breast tumors positive for oestrogen receptor and with spread to lymph nodes. Clin Pathol 38: 1229-1234
27. Victor SJ, Horwitz EM, Kini VR, Martinez AA, Pettinga JE, Dmuchowski CF, Decker DA, Wilner FM, Vicini FA (1999) Impact of clinical, pathologic, and treatment related factors on outcome in patients with locally advanced breast cancer treated with multimodality therapy. Am J Clin Oncol 22: 119-125
28. Walker LG, Heys SD, Walker MB, Ogston K, Miller ID, Hutcheon AW, Sarka TK, Ah-See AK, Eremin O (1999) Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer 35: 1783-1788
29. Weshler Z, Brufman G, Sulkes A, Warner-Efraty E, Ben-Baruch N, Biran S, Fuks Z (1990) Radiation therapy for locally advanced breast cancer: Prognostic factors and complication rate. Eur J Surg Oncol 16: 430-435
30. Zambetti M, Oriana S, Quarttrone P, Verderio P, Terenziani M, Zucali R, Valagussa P, Bondadonna G (1999) Combined sequential approach in locally advanced breast cancer. Ann Oncol 10: 305-310